Luiz Antonio Del Ciampo¹✉ and Ieda Regina Lopes Del Ciampo²
¹Department of Puericulture and Pediatrics. Faculty of Medicine of Ribeirão Preto. University of São Paulo. Brazil
²Department of Medicine. Federal University of São Carlos. Brazil
Received: Nov 20, 2022/ Revised: Dec 22, 2022/ Accepted: Dec 25, 2022
(✉) Corresponding Author: delciamp@fmrp.usp.br
Abstract
Genital human papillomavirus HPV infection is the most common sexually transmitted infection worldwide, involving men and women of all ages, and is associated with poor health outcomes. Particularly during adolescence, this health problem assumes greater proportions due to the behavioral characteristics of adolescents, which make them a person at high risk of contracting this infection. As they are in the process of physical, emotional, sexual, and social maturation, adolescents exhibit risky behaviors due to the beginning of sexual activities driven by pubertal development, most of the time without proper preventive guidance, which predisposes them to contact with several viral and bacterial pathogens. Characteristics such as impulsiveness, indifference to risks and dangers, feeling of invulnerability, motivation to explore and seek novelty, and the need to face challenges and challenge rules and models, are part of the adolescent’s emotional development process, whose maturation is established as the limbic system and prefrontal cortex establish their role in controlling emotions. In addition, the possibility of relating to many partners with alternative sexual behaviors, the absence of circumcision, and the non-use of condoms contribute to increasing the risk of many infections. Given this scenario, it is essential that all the circumstances related to HPV, the vaccine, and the difficulties of its wide coverage are known, so that measures are implemented that aim to offer greater protection to the most vulnerable population.
Keywords: Health problem, Viral, Bacterial Pathogens. HPV, Adolescent, and Vaccine
References
Akumbom, A. M., Lee, J. J., Reynolds, N. R., Thayer, W., Wang, J., & Slade, E. (2022). Cost and effectiveness of HPV vaccine delivery strategies: A systematic review. Preventive medicine reports, 101734.
Amboree, T. L., & Darkoh, C. (2021). Barriers to human papillomavirus vaccine uptake among racial/ethnic minorities: a systematic review. Journal of Racial and Ethnic Health Disparities, 8(5), 1192-1207.
Bednarczyk, R. A. (2019). Addressing HPV vaccine myths: practical information for healthcare providers. Human vaccines & immunotherapeutics, 15(7-8), 1628-1638.
Brianti, P., De Flammineis, E., & Mercuri, S. R. (2017). Review of HPV-related diseases and cancers. New Microbiol, 40(2), 80-85.
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., … & Bloem, P. (2021). HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Preventive medicine, 144, 106399.
Chido-Amajuoyi OG, Jackson I, Yuc R, Shete S. (2021). Declining awareness of HPV and HPV vaccine in the general US population. Human Vaccine & Immunotherapeutics 17:420–427.
Czajka, H. (2018). Why are preventive vaccinations still required?. Developmental Period Medicine, 22(2), 171-178.
Del Ciampo, L. A., & Del Ciampo, I. R. L. Physical, emotional and social aspects of vulnerability in adolescence.
Dilley, S., Miller, K. M., & Huh, W. K. (2020). Human papillomavirus vaccination: Ongoing challenges and future directions. Gynecologic oncology, 156(2), 498-502.
Karafillakis, E., Peretti-Watel, P., Verger, P., Chantler, T., & Larson, H. J. (2022). “We don’t have the same bodies; we don’t react the same way”: mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination in France. Human vaccines & immunotherapeutics, 18(1), 2036555.
Fernandes, J. V., & de Medeiros Fernandes, T. A. A. (2012). Human papillomavirus: biology and pathogenesis. In Human Papillomavirus and Related Diseases-From Bench to Bedside-A Clinical Perspective. IntechOpen.
Gallego, L. S., Dominguez, A., & Parmar, M. (2022). Human papilloma virus vaccine. In StatPearls [Internet]. StatPearls Publishing.
Iliadou, M., Sahini, K., Sakellari, E., Daglas, M., Orovou, E., Iatrakis, G., & Antoniou, E. (2021). What do Young People Think About HPV and HPV Vaccination? The Role of Health Education Interventions and Health Professionals. Materia Socio-medica, 33(3), 219.
Kiener, L. M., Schwendener, C. L., Jafflin, K., Meier, A., Reber, N., Maurer, S. S., … & Tarr, P. E. (2022). Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study. BMJ open, 12(4), e053754.
Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G. A., Zhou, Y., & Jin, T. (2021). Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Frontiers in public health, 8, 552028.
Lindsay, A. C., Delgado, D., Valdez, M. J., Restrepo, E., & Guzman, Y. M. (2020). “I don’t think he needs the HPV vaccine cause boys can’t have cervical cancer”: A qualitative study of Latina mothers’(mis) understandings about human papillomavirus transmission, associated cancers, and the vaccine. Journal of Cancer Education, 1-9.
Lismidiati, W., Emilia, O., & Widyawati, W. (2021). Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents. Asian Pacific Journal of Cancer Prevention: APJCP, 22(2), 471.
Manini, I. and Montomoli, E. (2018). Epidemiology, and prevention of Human Papillomavirus. Annali di Igiene 30 (Suppl. 1): 28-32.
Nicol, A. F., Andrade, C. V., Russomano, F. B., Rodrigues, L. L. S., Oliveira, N. S., & Provance Jr, D. W. (2016). HPV vaccines: a controversial issue?. Brazilian Journal of Medical and Biological Research, 49.
Ntanasis-Stathopoulos, I., Kyriazoglou, A., Liontos, M., Dimopoulos, M., & Gavriatopoulou, M. (2020). Current trends in the management and prevention of human papillomavirus (HPV) infection. J. BUON, 25, 1281-1285.
Ortiz, R. R., Smith, A., & Coyne-Beasley, T. (2019). A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Human vaccines & immunotherapeutics, 15(7-8), 1465-1475.
Padilha, R. F. N., Resende, M. A. A., Reis, M. D., Oliveira, V. C., Oliveira, P. P. and Carvalho, N. M. (2022). Reasons for parents and guardians for non-adherence to Human Papilloma Virus vaccination: Scoping Review. Research, Society and Development 11: 1-15.
Phillips, A., Hickie, M., Totterdell, J., Brotherton, J., Dey, A., Hill, R., … & Macartney, K. (2020). Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine, 38(38), 6038-6046.
Rosalik, K., Tarney, C. and Han, J. (2021). Human Papilloma virus vaccination. Viruses 13: 1-11.
Shapiro, G. K. (2022) HPV Vaccination: An underused strategy for the prevention of cancer. Current Oncology 29:3780–3792.
Shimabukuro, T. T., Su, J. R., Marquez, P. L., Mba-Jonas, A., Arana, J. E. and Cano, M. V. (2019). Safety of the 9-valent Human Papillomavirus vaccine. Pediatrics 144: 1-17.
Sobeczek, K., Gujski, M., & Raciborski, F. (2022). HPV Vaccination: Polish-Language Facebook Discourse Analysis. International Journal of Environmental Research and Public Health, 19(2), 914.
Sonawane, K., Zhu, Y., Lin, Y. Y., Damgacioglu, H., Lin, Y., Montealegre, J. R., & Deshmukh, A. A. (2021). HPV vaccine recommendations and parental intent. Pediatrics, 147(3).
Syrjänen, S. (2018). Oral manifestations of human papillomavirus infections. European journal of oral sciences, 126, 49-66.
Pereira da Veiga, C. R., Semprebon, E., da Silva, J. L., Lins Ferreira, V., & Pereira da Veiga, C. (2020). Facebook HPV vaccine campaign: insights from Brazil. Human vaccines & immunotherapeutics, 16(8), 1824-1834.
Wemrell, M., & Gunnarsson, L. (2022). Attitudes Toward HPV Vaccination in Sweden: A Survey Study. Frontiers in public health, 10.
WHO. (2027). Safety update of HPV vaccines. Weekly Epidemiological Record 92: 393-402.
Wikström, A. and Elfgren, K. (2021). HPV vaccines effective and safe. Lakartidningen 118:1-6.
Yousefi, Z., Aria, H., Ghaedrahmati, F., Bakhtiari, T., Azizi, M. and Bastan, R. (2022). An update on human papilloma virus vaccines: history, types, protection, and efficacy. Frontiers in Immunology 12, 1-11.
How to cite this article
Ciampo, L. A. D. and Ciampo, I. R. L. D. (2022). Genital human papilloma virus, adolescent and vaccine: a mini-review. Science Archives, Vol. 3(4), 332-335. https://doi.org/10.47587/SA.2022.3413
License Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
